Position in BBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$341,834,227
-$36,120,285 QoQ
Shares Held
4,589,611
-9.8% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
72.48%
of 13F equity value
Holder Rank
#10
of 472 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aisling Capital Management LP holds $451,349,309 across 13 Biotechnology names. BBIO ranks #1 (75.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
This page
|
4,589,611 | $341,834,227 | |
| 2 | GLUE |
Monte Rosa Therapeutics, Inc.
|
1,555,664 | $37,647,068 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,316,806 | $28,785,379 | |
| 4 | BCAX |
Bicara Therapeutics Inc.
|
568,919 | $16,891,205 | |
| 5 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
1,018,018 | $7,757,297 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
77,031 | $4,236,705 | |
| 7 | URGN |
UroGen Pharma Ltd.
|
108,000 | $3,974,400 | |
| 8 | BMEA |
Biomea Fusion, Inc.
|
2,048,757 | $3,011,672 |
All Filings in BBIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,834,227 | 4,589,611 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $377,954,512 | 5,089,611 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $389,304,345 | 5,089,611 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $316,294,395 | 6,089,611 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $262,021,637 | 6,068,125 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $209,775,081 | 6,068,125 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $166,509,350 | 6,068,125 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $154,494,462 | 6,068,125 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $153,705,606 | 6,068,125 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $187,626,425 | 6,068,125 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $244,970,206 | 6,068,125 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $160,016,456 | 6,068,125 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $104,371,750 | 6,068,125 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $100,609,512 | 6,068,125 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $46,239,112 | 6,068,125 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $60,317,162 | 6,068,125 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $55,098,575 | 6,068,125 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $61,591,468 | 6,068,125 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $101,216,325 | 6,068,125 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $284,413,018 | 6,068,125 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $369,912,900 | 6,068,125 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $373,796,500 | 6,068,125 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $283,687,087 | 3,989,412 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $149,682,738 | 3,989,412 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $130,094,725 | 3,989,412 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $115,692,948 | 3,989,412 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||